Diabetes mellitus affects hundreds of millions of individuals worldwide and represents a leading cause of visual impairment. While diabetic retinopathy remains the most extensively studied ocular complication, alterations in refractive status associated with fluctuations in blood glucose have long been recognized. Early clinical descriptions dating back to the early twentieth century documented transient refractive changes in patients with uncontrolled diabetes, establishing one of the earliest links between systemic metabolic disturbance and ocular optics [3].
Refractive instability in diabetes typically presents as either transient myopia or hyperopia and is often temporally associated with acute hyperglycaemia or the initiation of intensive glycaemic control [1,2,4]. Such changes may cause significant visual discomfort and frequently prompt ophthalmic consultation. Despite being reversible in many cases, these refractive shifts provide important insights into lens physiology and the biochemical consequences of elevated glucose.
The crystalline lens plays a central role in these phenomena. Experimental studies have demonstrated that hyperglycaemia activates the polyol pathway, leading to intracellular accumulation of sorbitol or dulcitol, osmotic lens swelling, and subsequent changes in refractive index [7,10]. Clinical imaging and biometric investigations further support structural lens alterations in diabetic eyes, including increased thickness and modified curvature [15,19].
Beyond acute refractive fluctuations, accumulating epidemiological evidence suggests a broader association between refractive status and diabetic retinopathy. Multiple population-based studies have reported that myopia and longer axial length are inversely associated with the prevalence and progression of diabetic retinopathy [20–26]. Meta-analyses reinforce these findings, indicating a consistent protective effect of myopia against retinal microvascular damage [21,30]. These observations raise intriguing questions regarding the role of ocular geometry in modulating diabetic retinal disease.
Understanding the relationship between blood glucose, refractive status, and diabetic retinopathy carries important clinical implications. Refractive measurements obtained during periods of glycaemic instability may be unreliable, and unrecognized transient shifts can lead to inappropriate spectacle prescriptions. Moreover, refractive status may represent a previously underappreciated biomarker for retinopathy risk stratification.
This review integrates historical observations, mechanistic research, and contemporary clinical evidence to provide a comprehensive overview of the correlation between blood sugar levels and refractive status. Particular emphasis is placed on (1) acute refractive changes associated with hyperglycaemia and treatment, (2) lens-based mechanisms underlying these changes, and (3) the emerging relationship between refractive error, axial length, and diabetic retinopathy.
Pathophysiological Basis of Refractive Changes in Diabetes:
Lens Osmotic Mechanisms and the Polyol Pathway-
The predominant mechanism underlying hyperglycaemiainduced refractive change involves altered lens metabolism. Elevated glucose concentrations in the aqueous humour diffuse into the lens, where glucose is converted to sorbitol via aldose reductase. Sorbitol, a polyol alcohol, diffuses poorly across lens membranes, resulting in intracellular accumulation and osmotic stress [7].
Classic experimental work demonstrated that galactosefed animal models developed lens swelling due to dulcitol accumulation, producing marked optical changes and cataract formation [10]. Similar mechanisms are believed to operate in human diabetes, with osmotic influx of water leading to lens fiber separation, increased lens thickness, and modifications in refractive index gradients.
Clinical observations support this biochemical framework. Huggert described characteristic alterations in lens appearance during transient refractive changes, suggesting dynamic shifts in lens hydration and structure [9]. Subsequent optical modelling studies further indicated that even small variations in lens refractive index or curvature can produce clinically meaningful refractive errors [14,16].
Structural Changes of the Crystalline Lens-
Modern imaging techniques have provided quantitative confirmation of lens alterations in diabetic eyes using Scheimpflug photography and biometric analysis, Wiemer and colleagues demonstrated that individuals with diabetes exhibit increased lens thickness, altered shape, and changes in equivalent refractive index compared with non-diabetic controls [19]. These structural modifications likely contribute both to transient refractive fluctuations and to longerterm refractive trends observed in diabetic populations.
Transient hyperopic shifts are commonly reported during the early phase of intensive glycaemic control. Saito et al. documented lens swelling accompanied by hyperopia in newly treated diabetic patients, attributing this phenomenon to rapid changes in lens osmolarity as blood glucose levels normalize [15]. Similar clinical patterns were described by Okamoto et al., who observed refractive instability during aggressive glucose lowering, emphasizing the need to delay spectacle prescription until metabolic control stabilizes [1].
Conversely, acute hyperglycaemia itself has been associated with transient myopia in several reports [2,8]. These opposing refractive responses highlight the dynamic interplay between lens hydration, refractive index, and curvature during fluctuating glycaemic states.
Accommodation and Neural Factors-
Although lens osmotic changes represent the primary mechanism, additional factors may contribute. Marmor described transient accommodative paralysis in diabetic patients, suggesting that neural or muscular dysfunction may compound refractive shifts in certain cases [12]. However, such mechanisms appear secondary compared with the dominant lens-based effects.
Acute Refractive Changes Associated withHyperglycaemia and Glycaemic Control
Transient Myopia in Hyperglycaemia-
Transient myopia during periods of uncontrolled hyperglycaemia has been documented for decades. Early clinical reports noted sudden onset of blurred distance vision coinciding with elevated serum glucose, which resolved as glycaemic control improved [2,8]. Duke-Elder provided one of the earliest systematic descriptions of refractive changes in diabetes, emphasizing their reversibility and close temporal relationship with metabolic status [3].
Fledelius examined refractive patterns in diabetic patients and observed a tendency toward myopic shifts during hyperglycaemic episodes, reinforcing the clinical relevance of glucose-dependent refractive variability [5]. These findings were supported by Friberg and Eller, who also described cases of transient hyperopia, underscoring the heterogeneity of refractive responses [6].
The variability in direction of refractive change likely reflects individual differences in lens structure, baseline refractive error, and the relative contributions of lens thickness versus refractive index alterations. Gwinup and Villarreal demonstrated a direct relationship between serum glucose concentration and refractive change magnitude, providing quantitative evidence for glucose-dependent optical effects [8].
Hyperopic Shifts During Treatment Initiation-
In contrast to hyperglycaemia associated myopia, initiation of insulin or intensive glycaemic therapy often precipitates transient hyperopia. Keller and Marmor independently reported cases of acute hyperopia following metabolic correction, attributing this phenomenon to rapid osmotic shifts within the lens [11,12]. Willi later summarized these observations, highlighting hyperopia as a common but underrecognized manifestation of improving glycaemic control [17].
Saito et al. provided detailed clinical documentation of lens swelling accompanying hyperopic shifts in newly treated diabetic patients, confirming that refractive instability can persist for several weeks after therapy initiation [15]. Okamoto and colleagues further emphasized that these changes are reversible and advised postponing refractive correction until stabilization occurs [1].
Giusti extended these findings to paediatric populations, describing transient hyperopic refractive changes in newly diagnosed juvenile diabetes, thereby demonstrating that age does not confer protection against glucose-related refractive instability [18].
Clinical Significance
From a practical standpoint, these acute refractive changes carry important implications. Premature spectacle prescription during periods of metabolic instability may result in inappropriate correction and patient dissatisfaction. Awareness of glucose-related refractive variability is therefore essential for both ophthalmologists and primary care providers managing diabetic patients.
Moreover, these transient optical phenomena provide a clinical window into lens physiology, illustrating how systemic metabolic disturbances translate into measurable changes in ocular refraction.
Refractive Status and Diabetic Retinopathy
Epidemiological Evidence Linking Myopia and Diabetic Retinopathy-
Over the past two decades, attention has shifted from transient refractive fluctuations toward the potential influence of baseline refractive status on diabetic retinopathy (DR). Several large-scale population studies have consistently reported an inverse association between myopia and DR prevalence.
Lim et al. were among the first to demonstrate that myopic eyes were less likely to exhibit DR in a multiethnic Asian cohort, suggesting that ocular geometry may modulate retinal microvascular disease [20]. Subsequently, Wang et al. performed a systematic review and meta-analysis confirming that myopia was significantly associated with reduced odds of DR, establishing refractive error as a potential protective factor [21]. Similar findings were reported in South Korea, where Chao et al. showed an inverse relationship between myopia and DR prevalence using national survey data [22].
Beyond refractive error alone, axial length has emerged as a critical parameter. Man, and colleagues demonstrated that longer axial length was protective against both DR and diabetic macular oedema in adults with diabetes, independent of traditional systemic risk factors [23]. Followup analyses revealed that reduced retinal capillary flow did not mediate this association, suggesting alternative structural or hemodynamic mechanisms [24]. The Kailuan Eye Study further corroborated these findings, reporting that increased axial length was independently associated with lower DR prevalence [25]. Longitudinal data also suggest that myopia may reduce the incidence and progression of DR over time [26].
Population-based investigations across Asia reinforce this pattern. Jee et al. identified refractive status as a significant factor in DR risk in Korean adults with type 2 diabetes [27], while Lin et al. reported that high myopia exerted a protective effect via thinning of the retinal vein in a large Chinese cohort [28]. More recently, Ten et al. analysed National Health and Nutrition Examination Survey data and confirmed that high myopia was associated with reduced DR prevalence in a representative population sample [29].
These observational findings have been strengthened by contemporary meta-analyses. Li et al. demonstrated a consistent inverse relationship between refractive error and DR risk across diverse populations, emphasizing axial length as a key mediator [30]. Fu et al. similarly concluded that longer axial length was associated with lower DR prevalence, reinforcing the concept that ocular elongation may mitigate diabetic retinal damage [32].
Structural and Hemodynamic Mechanisms-
Several hypotheses have been proposed to explain the protective association between myopia and DR. One leading theory centre’s on ocular geometry. Axial elongation increases retinal surface area, potentially reducing retinal capillary density and thereby lowering metabolic demand per unit area. This may attenuate hypoxia-driven vascular endothelial growth factor signalling and subsequent microvascular damage.
Additionally, myopic eyes often exhibit retinal and choroidal thinning, which may alter retinal perfusion dynamics. Lin et al. provided mechanistic evidence suggesting that thinning of the retinal vein in highly myopic eyes contributes to reduced hydrostatic pressure within the retinal circulation, thereby decreasing susceptibility to diabetic microangiopathy [28,38].
Man, et al. further explored these mechanisms and demonstrated that decreased retinal capillary flow did not account for the observed protective effect, indicating that structural factors such as axial length and retinal stretch may play more prominent roles [24]. Wang et al. proposed axial length as a central mediator linking myopia and DR, integrating biometric parameters into risk models for diabetic retinal disease [39].
Table 1. Proposed Mechanisms Linking Blood Glucose, Refractive Change, and Diabetic Retinopathy
|
Domain |
Mechanism |
Biological Basis |
Clinical Manifestation |
Key Supporting References |
|
Acute refractive change |
Polyol pathway activation |
Hyperglycemia → aldose reductase converts glucose to sorbitol → intracellular osmotic stress |
Transient myopia or hyperopia |
7, 10 |
|
Lens hydration |
Osmotic lens swelling |
Sorbitol accumulation draws water into lens fibers |
Increased lens thickness, altered curvature |
9, 15, 19 |
|
Optical properties |
Change in lens refractive index gradient |
Redistribution of lens proteins and water |
Temporary refractive instability |
14, 16 |
|
Treatment-related effects |
Rapid glycaemic correction |
Sudden reduction in plasma glucose reverses osmotic gradient |
Transient hyperopia during initiation of therapy |
1, 11, 12, 15 |
|
Structural ocular geometry |
Increased axial length in myopia |
Retinal stretching and reduced capillary density |
Lower prevalence of diabetic retinopathy |
23, 25, 32 |
|
Retinal hemodynamics |
Retinal vein thinning in high myopia |
Reduced hydrostatic pressure in retinal circulation |
Protective effect against microangiopathy |
28, 38 |
|
Metabolic demand |
Reduced retinal metabolic load |
Larger retinal surface area in myopic eyes |
Decreased hypoxia-driven vascular damage |
21, 30 |
|
Disease severity modulation |
Axial length as mediator |
Ocular elongation alters biomechanical and vascular environment |
Reduced risk of vision-threatening DR |
39, 42 |
Table 2. Summary of Key Clinical and Population Studies on Refractive Status and Diabetic Retinopathy
|
Author / Year |
Study Design |
Population |
Main Ocular Parameter |
Key Finding |
|
Lim et al., 2010 |
Population-based |
Asian cohort |
Refractive error |
Myopia inversely associated with DR |
|
Wang et al., 2016 |
Meta-analysis |
Multinational |
Refractive error |
Myopia significantly reduces DR risk |
|
Chao et al., 2016 |
National survey |
South Korea |
Myopia |
Lower DR prevalence in myopic eyes |
|
Man et al., 2012 |
Cohort |
Adults with diabetes |
Axial length |
Longer axial length protective for DR and DME |
|
Man et al., 2014 |
Mechanistic cohort |
Adults with diabetes |
Retinal flow |
Capillary flow not mediator of protection |
|
Wang et al., 2019 |
Population study |
Kailuan cohort |
Axial length |
Increased axial length independently protective |
|
Man et al., 2019 |
Longitudinal |
Adults with diabetes |
Myopia / axial length |
Reduced DR incidence and progression |
|
Lin et al., 2020 |
Cohort |
Chinese population |
High myopia |
Protection mediated via retinal vein thinning |
|
Ten et al., 2023 |
NHANES analysis |
US population |
High myopia |
High myopia associated with lower DR prevalence |
|
Li et al., 2024 |
Meta-analysis |
Multinational |
Refractive error & axial length |
Axial length identified as key mediator |
DR = diabetic retinopathy; DME = diabetic macular oedema.
Table 3. Clinical Studies Reporting Acute Refractive Changes Associated withHyperglycaemia and Glycaemic Control
|
Author / Year |
Study Type |
Population |
Glycaemic Context |
Direction of Refractive Change |
Principal Observation |
|
Duke-Elder, 1925 |
Clinical case series |
Adults with diabetes |
Poor glycaemic control |
Myopia / Hyperopia |
Early documentation of reversible refractive fluctuations |
|
Eva & Pascoe, 1982 |
Observational |
Adults with diabetes |
Hyperglycaemia |
Variable |
Transient refractive changes correlated with blood glucose |
|
Dickey et al., 1993 |
Case series |
Adults with acute hyperglycaemia |
Severe hyperglycaemia |
Myopia |
Sudden myopic shift resolving with glucose normalization |
|
Gwinup & Villarreal, 1976 |
Prospective |
Adults with diabetes |
Rising serum glucose |
Myopia predominance |
Linear relationship between serum glucose and refractive change |
|
Keller, 1973 |
Case report |
Adult diabetes |
Initiation of treatment |
Hyperopia |
Acute hyperopia during metabolic correction |
|
Marmor, 1973 |
Case series |
Adults with diabetes |
Treatment initiation |
Hyperopia |
Hyperopia with accommodative paralysis |
|
Saito et al., 1993 |
Clinical cohort |
Newly treated diabetes |
Intensive glycaemic control |
Hyperopia |
Lens swelling documented during early therapy |
|
Okamoto et al., 2000 |
Prospective cohort |
Adults with diabetes |
Intensive glucose lowering |
Hyperopia |
Refractive instability during glycaemic correction |
|
Giusti, 2003 |
Observational |
Juvenile diabetes |
Newly diagnosed |
Hyperopia |
Transient hyperopia in pediatric patients |
|
Fledelius, 1987 |
Clinical observation |
Adults with diabetes |
Hyperglycaemia |
Myopia |
Association between myopia and diabetic metabolic state |
|
Friberg & Eller, 1986 |
Case report |
Adult diabetes |
Hyperglycaemia |
Hyperopia |
Documented transient hyperopia |
Hyperglycaemia-related refractive changes are typically reversible within weeks following metabolic stabilization.
Refractive Error and Vision-Threatening Diabetic Retinopathy:
Beyond overall DR prevalence, refractive status also appears to influence the risk of vision-threatening disease. Li et al. reported that myopia was associated with reduced odds of proliferative DR and clinically significant macular oedema, suggesting that refractive error may modify disease severity in addition to occurrence [42]. Hainsworth et al. observed similar trends in individuals with type 1 diabetes, noting improved retinopathy outcomes in myopic patients [46].
These findings collectively support refractive status as a clinically relevant modifier of diabetic retinal disease. However, it is important to emphasize that myopia does not eliminate DR risk; rather, it appears to confer partial protection, underscoring the continued necessity of regular retinal screening.
Population Burden of Diabetic Retinopathy and Contextualization of Refractive Effects:
Globally, diabetic retinopathy remains a leading cause of vision impairment. Yau et al. estimated that over one-third of individuals with diabetes exhibit some degree of DR, with significant proportions progressing to vision-threatening stages [35]. Longitudinal studies such as the Beijing Eye Study reported substantial 10-year cumulative incidence rates, highlighting the progressive nature of diabetic retinal disease [36]. Similar prevalence patterns have been documented in large Chinese cohorts [37].
In South Korea, national surveys have detailed the burden of ocular disease in diabetic populations, revealing substantial prevalence of DR and other eye conditions [33,34]. Park et al. identified multiple systemic and ocular risk factors for DR in Korean adults with type 2 diabetes, while more recent analyses have projected rising DR prevalence in parallel with increasing diabetes rates [41,44]. Kim et al. further highlighted gaps in DR screening uptake, emphasizing ongoing barriers to early detection [43].
Within this epidemiological context, refractive status represents a potentially valuable, easily obtainable ocular parameter that may enhance DR risk stratification. Incorporating refractive error and axial length into predictive models could refine screening strategies and personalize follow-up intervals.
Clinical Implications
Refractive Assessment in Diabetic Patients-
Given the well-documented impact of glycaemic fluctuations on refraction, clinicians should exercise caution when prescribing corrective lenses to patients with unstable blood glucose. Transient myopic or hyperopic shifts may occur during periods of hyperglycemia or shortly after initiation of intensive therapy [1,2,15]. Delaying definitive refractive correction until metabolic stabilization is advisable to avoid inappropriate prescriptions.
Patient education is equally important. Individuals with newly diagnosed diabetes or undergoing treatment adjustments should be counselled regarding the possibility of temporary visual changes, which are typically reversible.
Refractive Status as a Modifier of Retinopathy Risk-
The growing body of evidence linking myopia and longer axial length with reduced DR risk suggests potential applications in clinical risk assessment. While refractive error alone should not dictate screening frequency, it may complement traditional risk factors such as diabetes duration, glycaemic control, blood pressure, and lipid status.
Incorporating ocular biometry into routine diabetic eye evaluations could facilitate more nuanced risk stratification. However, further prospective studies are required before formal guideline integration.
Implications for Screening and Public Health-
Despite the apparent protective association of myopia, all patients with diabetes require regular retinal screening. Population studies demonstrate substantial DR prevalence even among myopic individuals [29,35]. Therefore, refractive status should be viewed as a modifier rather than a determinant of screening necessity.
Public health initiatives must continue to prioritize early detection and equitable access to eye care, particularly in regions with rising diabetes prevalence and limited screening infrastructure.
Limitations of Current Evidence:
Several limitations characterize the existing literature. Many studies are cross-sectional, limiting causal inference. Definitions of myopia and DR vary across investigations, contributing to heterogeneity in pooled analyses. Additionally, most large cohorts are derived from Asian populations, potentially restricting generalizability to other ethnic groups.
Confounding factors, including cataract status, prior refractive surgery, and socioeconomic variables, may influence observed associations. Furthermore, while axial length appears central to the myopia–DR relationship, the precise biological mechanisms remain incompletely understood.
Future research should prioritize longitudinal, multiethnic studies incorporating detailed ocular biometry and advanced retinal imaging to clarify causal pathways.
The relationship between blood sugar levels and refractive status encompasses both acute, reversible optical changes and longer-term structural associations with diabetic retinopathy. Hyperglycemia and its treatment induce transient refractive shifts primarily mediated by osmotic alterations within the crystalline lens. These phenomena underscore the importance of metabolic stability in refractive assessment.
Beyond these short-term effects, mounting epidemiological evidence indicates that myopia and increased axial length are inversely associated with diabetic retinopathy prevalence and severity. Structural ocular factors, rather than retinal perfusion alone, likely underpin this protective relationship. While refractive status should not replace established risk factors, it represents a promising adjunct in DR risk stratification.
A comprehensive understanding of these interrelationships enhances clinical management of diabetic patients and opens avenues for refined screening strategies. Continued research integrating systemic, optical, and retinal parameters will be essential to fully elucidate the role of refractive status in diabetic eye disease.
[1] Okamoto F, Sone H, Nonoyama T, Hommura S. Refractive changes in diabetic patients during intensive glycaemic control. Br J Ophthalmol. 2000;84(10):1097-1102. doi:10.1136/bjo.84.10.1097.
[2] Dickey JB, Thompson HS, Smith S. Transient myopia accompanying acute hyperglycemia. South Med J. 1993;86(1):34-36. doi:10.1097/00007611-199301000-00009.
[3] Duke-Elder WS. Changes in refraction in diabetes mellitus. Br J Ophthalmol. 1925; 9:167-187. doi:10.1136/bjo.9.4.167.
[4] Eva PR, Pascoe PT. Transient refractive changes in diabetes mellitus. Br J Ophthalmol. 1982;66(1):20-24. doi:10.1136/bjo.66.1.20.
[5] Fledelius HC. Myopia and diabetes mellitus. Acta Ophthalmol (Copenh). 1987;65(5):530-534. doi:10.1111/j.1755-3768. 1987.tb08158. x.
[6] Friberg TR, Eller AW. Transient hyperopia in diabetes mellitus. Arch Ophthalmol. 1986;104(5):777-778. doi:10.1001/archopht.1986.01050170141040.
[7] Gabbay KH. Hyperglycemia, polyol metabolism, and diabetic complications. N Engl J Med. 1975;293(4):201-207. doi:10.1056/NEJM197507312930501.
[8] Gwinup G, Villarreal A. Relationship of serum glucose concentration to refractive change in diabetes. Diabetes. 1976;25(1):29-31. doi:10.2337/diab.25.1.29.
[9] Huggert A. The appearance of the crystalline lens during different stages of transitory changes of refraction. II. Acta Ophthalmol (Copenh). 1954;32(4):375-389. doi:10.1111/j.1755-3768. 1954.tb05057. x.
[10] Kinoshita JH, Merola LO, Satoh K, Dikmak E. Osmotic changes caused by the accumulation of dulcitol in the lenses of rats fed with galactose. Nature. 1962; 194:1085-1087. doi:10.1038/1941085a0.
[11] Keller JT. Hyperopia in diabetes. Arch Ophthalmol. 1973;90(6):511-512. doi:10.1001/archopht.1973.01000050511024.
[12] Marmor MF. Transient accommodative paralysis and hyperopia in diabetes. Arch Ophthalmol. 1973;89(5):419-421. doi:10.1001/archopht.1973.01000040421014.
[13] Perkins ES. Cataract: refractive error, diabetes, and morphology. Br J Ophthalmol. 1984;68(5):293-297. doi:10.1136/bjo.68.5.293.
[14] Planten JT. Changes of refraction in the adult eye due to changing refractive indices of the layers of the lens. Ophthalmologica. 1981;183(2):86-90. doi:10.1159/000309145.
[15] Saito Y, Ohmi G, Kinoshita S, Nakamura Y, Ogawa K, Harino S, Okada M. Transient hyperopia with lens swelling at initial therapy in diabetes. Br J Ophthalmol. 1993;77(3):145-148. doi:10.1136/bjo.77.3.145.
[16] Smith G, Atchison DA, Pierscionek BK. Modeling the power of the aging human eye. J Opt Soc Am A. 1992;9(12):2111-2117. doi:10.1364/JOSAA.9.002111.
[17] Willi MJ. Hyperopia and hyperglycemia. Surv Ophthalmol. 1996;41(2):187. doi:10.1016/S0039-6257(96)80019-1.
[18] Giusti C. Transient hyperopic refractive changes in newly diagnosed juvenile diabetes. Swiss Med Wkly. 2003;133(13-14):200-205. doi:10.4414/smw.2003.10177.
[19] Wiemer NGM, Dubbelman M, Kostense PJ, Ringens PJ, Polak BCP. The influence of diabetes mellitus type 1 and 2 on the thickness, shape, and equivalent refractive index of the human crystalline lens. Ophthalmology. 2008;115(10):1679-1686. doi: 10.1016/j.ophtha.2008.03.019.
[20] Lim LS, Lamoureux E, Saw SM, Tay WT, Mitchell P, Wong TY. Are myopic eyes less likely to have diabetic retinopathy? Ophthalmology. 2010;117(3):524-530. doi: 10.1016/j.ophtha.2009.07.044.
[21] Wang X, Tang L, Gao L, Yang Y, Cao D, Li Y. Myopia and diabetic retinopathy: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2016; 111:1-9. doi: 10.1016/j.diabres.2015.10.020.
[22] Chao DL, Lin SC, Chen R, Lin SC. Myopia is inversely associated with the prevalence of diabetic retinopathy in the South Korean population. Am J Ophthalmol. 2016; 172:39-44. doi: 10.1016/j.ajo.2016.09.011.
[23] Man REK, Sasongko MB, Best WJ, et al. Longer axial length is protective of diabetic retinopathy and macular edema. Ophthalmology. 2012;119(9):1754-1759. doi: 10.1016/j.ophtha.2012.03.021.
[24] Man REK, Sasongko MB, Sanmugasundram S, et al. Decreased retinal capillary flow is not a mediator of the protective myopia–diabetic retinopathy relationship. Invest Ophthalmol Vis Sci. 2014; 55:6901-6907. doi:10.1167/iovs.14-15137.
[25] Wang Q, Wang YX, Wu SL, et al. Ocular axial length and diabetic retinopathy: the Kailuan Eye Study. Invest Ophthalmol Vis Sci. 2019;60(10):3689-3695. doi:10.1167/iovs.19-27531.
[26] Man REK, Gan ATL, Gupta P, et al. Is myopia associated with the incidence and progression of diabetic retinopathy? Am J Ophthalmol. 2019; 208:226-233. doi: 10.1016/j.ajo.2019.05.012.
[27] Jee D, Lee WK, Kang S. Prevalence and risk factors for diabetic retinopathy: the Korea National Health and Nutrition Examination Survey 2008-2011. Invest Ophthalmol Vis Sci. 2013;54(10):6827-6833. doi:10.1167/iovs.13-12654.
[28] Lin Z, Li D, Zhai G, et al. High myopia is protective against diabetic retinopathy via thinning retinal vein: a report from Fushun Diabetic Retinopathy Cohort Study (FS-DIRECT). Diabetes Vasc Dis Res. 2020;17(4):1479164120940988. doi:10.1177/1479164120940988.
[29] Ten W, Yuan Y, Zhang W, et al. High myopia is protective against diabetic retinopathy in the participants of the National Health and Nutrition Examination Survey. BMC Ophthalmol. 2023; 23:468. doi:10.1186/s12886-023-03191-x.
[30] Li Y, Xie X, et al. The relationship between refractive error and the risk of diabetic retinopathy: a systematic review and meta-analysis. Front Med (Lausanne). 2024; 11:1354856. doi:10.3389/fmed.2024.1354856.
[31] Kulshrestha S, Thakur S, Raina UK, et al. Interrelationship of ocular parameters with refractive error in diabetes: a population-based analysis. Sci Rep. 2022;12: doi:10.1038/s41598-022-11220-w.
[32] Fu Y, Geng Y, et al. Axial length and diabetic retinopathy: a systematic review and meta-analysis. Acta Ophthalmol. 2016;94: doi:10.1111/aos.12908.
[33] Kim TN, Lee JE, Lee EJ, et al. Prevalence of and factors associated with lens opacities in a Korean adult population with and without diabetes: the 2008–2009 Korea National Health and Nutrition Examination Survey. PLoS One. 2014;9(4): e94189. doi: 10.1371/journal.pone.0094189.
[34] Yoon KC, Mun GH, Kim SD, et al. Prevalence of eye diseases in South Korea: data from the Korea National Health and Nutrition Examination Survey 2008-2009. Korean J Ophthalmol. 2011;25(6):421-433. doi:10.3341/kjo.2011.25.6.421.
[35] Yau JWY, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556-564. doi:10.2337/dc11-1909.
[36] Xu J, Wei WB, Yuan MX, et al. Ten-year cumulative incidence of diabetic retinopathy: the Beijing Eye Study. PLoS One. 2014;9(10): e111320. doi: 10.1371/journal.pone.0111320.
[37] Hu Y, Teng W, Liu L, et al. Prevalence and risk factors of diabetes and diabetic retinopathy in Liaoning province, China: a population-based cross-sectional study. PLoS One. 2015;10: e0121477. doi: 10.1371/journal.pone.0121477.
[38] Lin Z, Li D, Zhai G, et al. High myopia is protective against diabetic retinopathy via thinning retinal vein: mechanistic insights. Diab Vasc Dis Res. 2020;17(4):1479164120940988. doi:10.1177/1479164120940988.
[39] Wang X, Tang L, Gao L, et al. Myopia and diabetic retinopathy: axial length as key mediator. Diabetes Res Clin Pract. 2016; 111:1-9. doi: 10.1016/j.diabres.2015.10.020.
[40] Okamoto F, Sone H, Nonoyama T, Hommura S. Intensive glycaemic control and transient hyperopia: clinical observations. Br J Ophthalmol. 2000;84(10):1097-1102. doi:10.1136/bjo.84.10.1097.
[41] Park CY, Lee JL, et al. Prevalence and risk factors for diabetic retinopathy in Koreans with type 2 diabetes. Ophthalmic Epidemiol. 2012; 19: doi:10.3109/09286586.2012.
[42] Li Y, et al. Association between refractive error and vision-threatening diabetic retinopathy. Front Med (Lausanne). 2024; 11:1354856. doi:10.3389/fmed.2024.1354856.
[43] Kim MS, et al. Trends and barriers in diabetic retinopathy screening. J Korean Med Sci. 2024;39: e203. doi:10.3346/jkms.2024.39. e203.
[44] Nam S, Kim MS, Lee J, Woo SJ. Nationwide trends and future projections of diabetes and diabetic retinopathy prevalence in Korea. J Korean Med Sci. 2026;41: e31. doi:10.3346/jkms.2026.41. e31.
[45] Quigley MG, et al. Axial length and diabetic retinopathy. Invest Ophthalmol Vis Sci. 2013;54: doi:10.1167/iovs.13-.
[46] Hainsworth DP, et al. Refractive error and retinopathy outcomes in type 1 diabetes. Ophthalmology. 2021; 128:doi: 10.1016/j.ophtha.2020.10.016.
[47] Lin Z, et al. High myopia and diabetic retinopathy: cohort evidence. Diab Vasc Dis Res. 2020;17(4):1479164120940988. doi:10.1177/1479164120940988.
[48] Ten W, et al. High myopia protective association with diabetic retinopathy: NHANES analysis. BMC Ophthalmol. 2023; 23:468. doi:10.1186/s12886-023-03191-x.
[49] Chao DL, et al. Refractive status and diabetic retinopathy in South Korea: KNHANES. Am J Ophthalmol. 2016; 172:39-44. doi: 10.1016/j.ajo.2016.09.011.
[50] Lim LS, et al. Refractive error, axial length, and diabetic retinopathy in SiMES. Ophthalmology. 2010;117(3):524-530. doi: 10.1016/j.ophtha.2009.07
IJBMR -ISSN: 0976:6685. ©Copyright 2026 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by BioMedSciDirect Publications